Both Dapa and Lira treatment and their combination significantly suppressed both the hepatic and renal expression of both of NF-κB and TNF-α, confirming the suppressive impact of DM-induced canonical NF-κB activation and inflammation. This evidence concerns the gene TNF and diabetes mellitus.